Is Spinal muscular atrophy with respiratory distress type 1 hereditary?

Spinal muscular atrophy with respiratory distress type 1 (SMARD1) is an inherited genetic condition caused by mutations in the IGHMBP2 gene. It follows an autosomal recessive inheritance pattern, meaning a child must inherit two copies of the mutated gene—one from each carrier parent—to develop the disease.

Is Spinal muscular atrophy with respiratory distress type 1 hereditary?

Yes, Spinal muscular atrophy with respiratory distress type 1 is a hereditary condition. Because it is autosomal recessive, parents who are both carriers of an IGHMBP2 mutation do not typically show symptoms but have a 25% chance with each pregnancy of having a child affected by Spinal muscular atrophy with respiratory distress type 1. It is not considered a multifactorial or spontaneous (de novo) condition in the vast majority of cases.

How is genetic risk determined for families?

Genetic counseling is essential for families impacted by Spinal muscular atrophy with respiratory distress type 1. A clinical geneticist can provide precise risk assessments based on family history and molecular testing. Key considerations include:

• Carrier Testing: Siblings and extended family members of an affected individual can undergo genetic testing to determine if they carry a mutation in the IGHMBP2 gene.


• Prenatal Diagnosis: Couples known to be carriers have options such as chorionic villus sampling (CVS) or amniocentesis during pregnancy.


• Preimplantation Genetic Testing (PGT): Families may choose to undergo IVF with PGT to select embryos that do not carry the mutations associated with Spinal muscular atrophy with respiratory distress type 1.

When should genetic testing be performed?

Genetic testing for Spinal muscular atrophy with respiratory distress type 1 is recommended as soon as clinical symptoms—such as respiratory distress and progressive muscle weakness—are observed in an infant. Confirmatory molecular genetic testing of the IGHMBP2 gene is the gold standard for diagnosis. Currently, 47 members of the DiseaseMaps.org community have shared their experiences, highlighting the importance of early genetic confirmation in navigating care.

Next steps

• Consult with a board-certified clinical geneticist to discuss family screening.


• Connect with the Spinal muscular atrophy with respiratory distress type 1 community at DiseaseMaps.org to share resources and experiences.


• Request a referral to a pediatric neurologist specializing in motor neuron diseases.

Medical disclaimer: This information is for educational purposes only and should not replace professional medical advice, diagnosis, or treatment.

References

• NIH Genetic and Rare Diseases Information Center (GARD): Spinal muscular atrophy with respiratory distress type 1.


• Orphanet: IGHMBP2-related disorders.


• OMIM (Online Mendelian Inheritance in Man): Spinal muscular atrophy with respiratory distress 1; SMARD1.